Kumpulan Info tentang,
UNIVERSITAS SURABAYA
| No | Source Title | CiteScore | Quartile | Publisher | Highest percentile | Citations 2021-24 | Documents 2021-24 |
|---|---|---|---|---|---|---|---|
| 871 | Diabetes, Metabolic Syndrome and Obesity | 5.2 | Q2 | Dove Medical Press | 67.0% 56/171 Internal Medicine | 7814 | 1505 |
| 872 | Contemporary Clinical Trials Communications | 2.6 | Q2 | Elsevier | 67.0% 215/668 General Medicine | 1663 | 649 |
| 873 | Journal of Pharmacological Sciences | 6.2 | Q2 | Japanese Pharmacological Society | 67.0% 104/321 Pharmacology | 2381 | 385 |
| 874 | Pharmaceutical Science Advances | 2.3 | Q2 | Elsevier | 66.0% 16/46 Pharmacology, Toxicology and Pharmaceutics (miscellaneous) | 99 | 44 |
| 875 | PharmacoEconomics - Open | 4.1 | Q2 | Springer Nature | 66.0% 108/320 Health Policy | 1145 | 280 |
| 876 | Journal of Xenobiotics | 6 | Q2 | Multidisciplinary Digital Publishing Institute (MDPI) | 66.0% 107/321 Pharmacology | 1178 | 196 |
| 877 | Biomarker Insights | 5.3 | Q2 | SAGE | 63.0% 28/76 Biochemistry (medical) | 417 | 78 |
| 878 | Farmatsiya i Farmakologiya | 1.2 | Q2 | Volgograd State Medical University, Pyatigorsk Medical and Pharmaceutical Institute | 61.0% 4/9 Pharmacology (nursing) | 176 | 152 |
| 879 | BMC Pharmacology and Toxicology | 4.7 | Q2 | Springer Nature | 61.0% 106/275 Pharmacology (medical) | 1603 | 339 |
| 880 | Natural Product Communications | 2.6 | Q2 | SAGE | 60.0% 45/112 Complementary and Alternative Medicine | 2631 | 1011 |
| 881 | Clinical and Experimental Vaccine Research | 3.7 | Q2 | Korean Vaccine Society | 60.0% 274/687 Public Health, Environmental and Occupational Health | 547 | 146 |
| 882 | Acta Pharmaceutica | 4.5 | Q2 | Hrvatsko Farmaceutsko Drustvo | 58.0% 78/185 Pharmaceutical Science | 756 | 169 |
| 883 | Emerging Trends in Drugs, Addictions, and Health | 3 | Q2 | Elsevier | 58.0% 181/433 Medicine (miscellaneous) | 222 | 75 |
| 884 | Journal of Pharmacopuncture | 2.5 | Q2 | Korean Pharmacopuncture Institute | 56.0% 49/112 Complementary and Alternative Medicine | 365 | 146 |
| 885 | Neuropsychopharmacology Reports | 3.3 | Q2 | John Wiley & Sons | 56.0% 136/313 Clinical Psychology | 1063 | 325 |
| 886 | International Journal of Immunopathology and Pharmacology | 4.6 | Q2 | SAGE | 51.0% 157/321 Pharmacology | 1438 | 314 |
| 887 | Herba Polonica | 2.1 | Q2 | Institute of Natural Fibres and Medicinal Plants - National Research Institute | 50.0% 56/112 Complementary and Alternative Medicine | 111 | 52 |
| 888 | Farmacia Hospitalaria | 1.4 | Q2 | Elsevier | 50.0% 24/47 Pharmacy | 352 | 252 |
| 889 | Antiviral Therapy | 3.8 | Q2 | SAGE | 50.0% 176/357 Infectious Diseases | 430 | 114 |
| 890 | Current Issues in Pharmacy and Medical Sciences | 1.2 | Q3 | Medical University of Lublin | 49.0% 337/668 General Medicine | 164 | 138 |
| 891 | Revista Espanola de Quimioterapia | 3.9 | Q3 | Sociedad Espanola de Quiminoterapia | 48.0% 77/148 Microbiology (medical) | 1260 | 323 |
| 892 | Intelligent Pharmacy | 2.7 | Q3 | KeAi Communications Co. | 46.0% 99/185 Pharmaceutical Science | 297 | 112 |
| 893 | Drugs in R and D | 4.1 | Q3 | Springer Nature | 46.0% 173/321 Pharmacology | 644 | 156 |
| 894 | Pharmacogenomics and Personalized Medicine | 4.2 | Q3 | Dove Medical Press | 46.0% 171/321 Pharmacology | 1523 | 366 |
| 895 | Journal of Medicinal Plants | 2 | Q3 | Institute of Medicinal Plants, ACECR | 45.0% 61/112 Complementary and Alternative Medicine | 215 | 109 |
| 896 | Toxicology Communications | 1.3 | Q3 | Taylor & Francis | 39.0% 264/433 Medicine (miscellaneous) | 115 | 87 |
| 897 | Current Therapeutic Research - Clinical and Experimental | 2.6 | Q3 | Elsevier | 39.0% 167/275 Pharmacology (medical) | 353 | 134 |
| 898 | Farmaceuticos Comunitarios | 0.4 | Q3 | Sociedad Espanola de Farmacia Clinica Familiar y Comunitaria | 38.0% 6/9 Pharmacology (nursing) | 38 | 102 |
| 899 | Frontiers in Antibiotics | 2 | Q3 | Frontiers Media S.A. | 32.0% 240/357 Infectious Diseases | 124 | 62 |
| 900 | Pharmaceutical Fronts | 1.2 | Q3 | Thieme | 32.0% 125/185 Pharmaceutical Science | 132 | 109 |